Gene dosage effects of poly(A) track-engineered hypomorphs

Keyphrases

• Gene Dosage 100%
• Poly(A) 100%
• Hypomorph 100%
• AUF1 66%
• Hypomorphic mutants 50%
• Cas9 Protein 33%
• Membrane Protein 33%
• Tumor Protein p53 (TP53) 33%
• Human Genes 16%
• Protein Level 16%
• Hypomorphic mutation 16%
• MRNA Level 16%
• Protein Expression 16%
• Gene Function 16%
• Cancer Cells 16%
• Secretory Proteins 16%
• In Cancer 16%
• Attenuation 16%
• Interleukin-2 16%
• Coding Sequence 16%
• MRNA Stability 16%
• Endogenous Genes 16%
• Endogenous Protein 16%
• Cellular Pathways 16%
• Regulatory Sequence 16%
• Functional Characterization 16%
• Functional Analysis 16%
• Engineered Cells 16%
• Target Molecule 16%
• P53 Protein 16%
• Biological Relevance 16%
• Recombinant Gene 16%
• Gene Level 16%
• CD20 16%
• Affective Expression 16%
• Gene Activity 16%
• Engineering Tools 16%
• Targeted Insertion 16%
• Adenosine nucleotides 16%

Biochemistry, Genetics and Molecular Biology

• CRISPR/Cas9 100%
• Gene Dosage 100%
• Cancer Cell 50%
• Membrane Protein 50%
• Transmembrane Protein 50%
• P53 50%
• Gene Function 50%
• Regulatory Sequence 50%
• Protein Expression 50%
• mRNA Stability 50%
• Interleukin 2 50%
• Gene Activity 50%
• CD20 50%
• Messenger RNA 50%
• Adenosine 50%

Medicine and Dentistry

• Gene Dosage 100%
• Polyadenylic Acid 100%
• Heterogeneous Nuclear Ribonucleoprotein D 66%
• Clustered Regularly Interspaced Short Palindromic Repeat 33%
• Cas9 33%
• Cancer Cell 16%
• Protein 16%
• Protein P53 16%
• Gene Function 16%
• Protein Expression 16%
• Membrane Protein 16%
• CD20 16%
• Interleukin 2 16%
• Adenosine 16%
• Secretory Protein 16%
• Engineered Cell 16%
• mRNA Stability 16%
• Gene Activity 16%
• Messenger RNA 16%
• Regulatory Sequence 16%